Medicine
Volume 38, Issue 2 , Pages 84-92, February 2010

Small vessel vasculitides

Lorraine Harper PhD MRCP is a Senior Lecturer/Consultant Nephrologist at the University of Birmingham and Queen Elizabeth Hospital Birmingham, UK and is currently Secretary of the Renal Association. Competing interests: none declared

Mark A Little PhD MRCPI is a Senior Lecturer/Consultant Nephrologist at University College London and Royal Free Hospital, London, UK. Competing interests: none declared

Abstract 

Small vessel vasculitis can be associated with immune complex deposition, as in Henoch–Schönlein purpura or systemic lupus erythematosus, or with minimal immune deposits, as in Wegener's granulomatosis, microscopic polyangiitis or renal-limited vasculitis. The latter conditions are associated with circulating anti-neutrophil cytoplasm antibodies (ANCA) and are the most common causes of rapidly progressive glomerulonephritis. This review describes recent advances in the understanding of the pathogenesis underlying these conditions and reviews common presentations. Consideration is given to recent clinical trials in the management of ANCA-associated vasculitides.

Keywords: ANCA, anti-neutrophil cytoplasm antibodies, microscopic polyangiitis, therapy, vasculitis, Wegener's granulomatosis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1357-3039(09)00301-6

doi:10.1016/j.mpmed.2009.10.008

Medicine
Volume 38, Issue 2 , Pages 84-92, February 2010